Skip to main content
ConductScienceScienceDex

Jan Van Deursen

FY2026 NIH rank #21,573
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 80067507Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$818.8K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#21,573
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jan Van Deursen. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Jan Van Deursen as a PI. Multi-PI records show the full award amount for context.

  • 4R44CA310319-02R44Co-investigator
    The SynthNode Paradigm: Reimagining CAR T Cell Therapy for Improved Patient Outcomes
    Persistence Therapeutics, Inc.
    $818.8K
    award amount

Award organization

Organizations that administered FY2026 awards listing Jan Van Deursen as a PI.

FY2026 award administered by Persistence Therapeutics, Inc. (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Persistence Therapeutics, Inc.
  2. 2026
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Jan Van Deursen.

Pritha Agarwalla
Persistence Therapeutics, Inc.
2
shared awards

Explore further

Find collaborators for Jan Van Deursen

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →